• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue adhd medication in the uk medication during pregnancy and nursing is challenging for women with the condition. Little data exists about how long-term exposure to these medications could affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge that more high quality studies are required.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication need to weigh the benefits of taking it against the possible dangers for the baby. Physicians don't have the data needed to make unequivocal recommendations however they can provide information regarding benefits and risks that can aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who used ADHD medications in early pregnancy did not face an higher risk of fetal cardiac malformations or major structural birth defects. Researchers used a large population-based study of case control to compare the incidence of major structural defects in infants who were born to mothers who used stimulants during pregnancy. Pediatric cardiologists and clinical geneticists looked over the cases to ensure an accurate classification of the cases and to reduce the possibility of bias.

However, the study was not without its flaws. Researchers were unable in the beginning, to separate the effects caused by the medication from the disorder. This limitation makes it difficult for researchers to determine whether the small differences observed between the groups that were exposed to the use of medications or if they were affected by co-morbidities. In addition, the researchers did not look at long-term offspring outcomes.

The study revealed that infants whose mother took ADHD medication during pregnancy had a higher risk of admission to the neonatal care unit (NICU) as compared to those whose mothers didn't take any medication during pregnancy or stopped taking their medication before or during pregnancy. This increase was caused by central nervous system disorders. The increased risk of admission was not influenced by the stimulant medication that was used during pregnancy.

Women who used stimulant ADHD medication during pregnancy were also at an elevated chance of having a caesarean section or having a baby born with an low Apgar score (less than 7). These increases did appear to be unrelated to the type of medication used during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy may be offset by the higher benefit to both the mother and child from continued treatment for the woman's condition. Physicians should speak with their patients about this and as much as possible, assist them improve coping skills which may reduce the impact of her disorder in her daily functioning and her relationships.

Interactions with Medication

More and more doctors are confronted with the dilemma of whether to keep treatment or stop during pregnancy as more women are diagnosed with ADHD. Most of the time, these decisions are made in the absence of any evidence that is clear and definitive in either case, which means that doctors have to weigh their experience about their experiences, the experiences of other doctors, and what research suggests about the subject as well as their own best judgment for each patient.

Particularly, the subject of potential risks to the baby can be tricky. The research on this issue is based on observation instead of controlled studies and the results are conflicting. The majority of studies limit their analysis to live-births, which could underestimate the teratogenic impact which can cause terminations or abortions of pregnancy. The study presented in this journal club addresses these shortcomings by analyzing data on live and deceased births.

Conclusion Some studies have shown a positive correlation between Adhd Medication Uk Elvanse medications and certain birth defects However, other studies haven't found a correlation. Most studies show that there is a neutral, or slight negative effect. Therefore an accurate risk-benefit analysis must be done in each instance.

For many women with ADHD and ADD, the decision to stop medication is difficult, if not impossible. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of isolation. A loss of medication may affect the ability to safely drive and complete work-related tasks, which are essential aspects of everyday life for those with ADHD.

She recommends women who are uncertain about whether to continue or discontinue medication due to their pregnancy, consider informing family members, friends and colleagues about the condition, its effects on daily functioning, and on the benefits of keeping the current treatment plan. In addition, educating them can make the woman feel more comfortable when she is struggling with her decision. Certain medications can be passed through the placenta. If a woman decides not to take her ADHD medication while breastfeeding, it's important to be aware that the medication could be passed on to her infant.

Risk of Birth Defects

As the use and abuse of inattentive adhd medication adults medication to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD) is increasing as does the concern about the possible effects of the drugs on foetuses. A study that was published in the journal Molecular Psychiatry adds to the body of knowledge about this subject. Using two massive data sets researchers were able analyze more than 4.3 million pregnancies and determine whether the use of stimulant medications increased the risk of birth defects. Researchers discovered that, while the risk overall is low, first-trimester ADHD medication use was associated with slightly higher risk of certain heart defects, like ventriculoseptal defects.

The authors of the study found no link between the use of early medications and other congenital anomalies, such as facial clefting or club foot. The results are in line with previous studies that have shown a small but significant increase in the risk of developing cardiac malformations in women who started taking ADHD medications prior to the time of pregnancy. The risk was higher during the latter part of pregnancy, when a lot of women decide to stop taking their ADHD medications.

Women who took ADHD medication during the first trimester were more likely to need a caesarean or have an insufficient Apgar after delivery and have a baby that needed help breathing after birth. The researchers of the study were not able to eliminate bias due to selection because they limited the study to women with no other medical conditions that could have contributed to the findings.

Researchers hope that their research will provide doctors with information when they see pregnant women. The researchers suggest that, while discussing benefits and risks are important, the decision on whether to continue or stop taking medication should be in light of the severity of each woman's ADHD symptoms and the needs of the woman.

The authors caution that, even though stopping the medication is a possibility to think about, it isn't recommended due to the high prevalence of depression and mental health issues in women who are expecting or have recently given birth. Further, research shows that women who stop taking their medication for inattentive adhd will have a harder adjustment to life without them after the baby is born.

Nursing

The responsibilities of a new mother can be overwhelming. Women with ADHD who must work through their symptoms while attending physician appointments and getting ready for the arrival of a child and getting used to new routines at home are often faced with a number of difficulties. Many women choose to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications are absorbed through breast milk in very small quantities, so the risk to breastfeeding infant is minimal. However, the frequency of medication exposure to the newborn may differ based on dosage, how often it is taken and the time of day the medication is administered. Additionally, different medications enter the baby’s system through the gastrointestinal tract or through breast milk. The impact of these medications on the health of a newborn is not completely known.

Because of the lack of research, some physicians may be inclined to discontinue stimulant medications during a woman's pregnancy. This is a difficult choice for the patient, who must balance the benefits of continuing her medication against the potential dangers to the embryo. Until more information becomes available, GPs may inquire about pregnant patients whether they have a history of ADHD or if they plan to take medication during the perinatal stage.

Numerous studies have demonstrated that women can continue to take their ADHD medication without risk during pregnancy and while breast-feeding. In response, a rising number of patients are choosing to do so. They have found after consulting with their doctors that the benefits of keeping their current medication outweigh possible risks.

Women who suffer from ADHD who are planning to breastfeed should seek the advice of an expert psychiatrist prior to becoming pregnant. They should discuss their medication with their physician and discuss the advantages and disadvantages of continued treatment, including non-pharmacological strategies. Psychoeducation is also required to help pregnant people with ADHD understand their symptoms and the root cause Learn about the available treatment options and strengthen existing strategies for coping. This should be a multidisciplinary approach, which includes the GP, obstetricians and psychiatry. Pregnancy counseling should include a discussion of a treatment plan for the mother as well as the child, as well as monitoring for signs of deterioration and, if needed modifications to the medication regime.